Abstract
Introduction: Kawasaki disease (KD) is an acute multisystem vasculitis of unknown etiology, occurring mainly in infants and small children. One of the most frequent complications are the cardiac manifestations associated with coronary anomalies, including diffuse dilatation and formation of coronary aneurysms that may lead to early acute myocardial infarction and cardiovascular complications. Objective: to describe the Myocardial Perfusion Imaging (MPI) findings with isonitrile using Single Photon Emission Computed Tomography (SPECT) in 14 patients with a clinical diagnosis of Kawasaki disease. Methodology: medical records from the database of the nuclear medicine department of the Reina Sofia Clinic were reviewed from January 2014 through July 2014. The purpose was to collect data from patients referred from the pediatric cardiology outpatient unit to the nuclear medicine department, in order to perform a Myocardial Perfusion with Isonitriles. Results: the sample included medical records and images from 14 patients (57% females). The average age at diagnosis of the KD was 20 months; the time elapsed between the diagnosis and the IgG administration was 3-5 days. In 100% of the patients, the MPI was reported as normal. Conclusion: early diagnosis of Kawasaki Disease and the administration of IgG y within the first 10 days after the onset of symptoms could be associated with the development of less coronary complications. The Myocardial Perfusion with Isonitriles (MPI) trial has been shown to be a valuable non-invasive diagnostic tool for the evaluation and follow-up of these patients.
References
Jane C. Burns, Howard I. Kushner, John F. Bastian, et al. Kawasaki Disease: A Brief History. Pediatrics 2000; 106; e27. https://doi.org/10.1542/peds.106.2.e27
Javier P. Petit. Enfermedad de Kawasaki. Arch Pediatr Urug 2003; 74(2): 99-113.
L.M. Prieto Tato, M.T.Cuesta, Rubio, S.Guillen Martin, et al. Enfermedad de Kawasaki: diagnóstico y tratamiento. An Pediatr (Barc).2010; 73(1):25-30. https://doi.org/10.1016/j.anpedi.2010.02.015
Dajani AS, Taubert KA, Takahashi M et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 89: 916-22. https://doi.org/10.1161/01.CIR.89.2.916
Fu YC, Kao CH, Hwang B, Jan SL, Chi CS. Discordance between dypiridamole stress Tc-sestamibi SPECT and coronary angiography in patients with Kawasaki disease. J. Nucl. Cardiol. 2002; 9: 41-6. https://doi.org/10.1067/mnc.2002.118238
Kelly JD, Forster AM, Higley B, et al. Technetium-99mtetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
L.M. Prieto Tato, M.T.Cuesta, Rubio, S.Guillen Martin, et al. Enfermedad de Kawasaki: diagnóstico y tratamiento. An Pediatr (Barc).2010;73(1):25-30. https://doi.org/10.1016/j.anpedi.2010.02.015
Dhillon R, Clarckson P, Donald AE et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 2103-6. https://doi.org/10.1161/01.CIR.94.9.2103
Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment and long-term management of Kawasaki disease. Circulation 2004; 110: 2747-7. https://doi.org/10.1161/01.CIR.0000145143.19711.78
Furuyama H, Odagawa Y, Katoh C et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J. Pediatr. 2003; 142: 149-54. https://doi.org/10.1067/mpd.2003.46
Fukuda T, Ishibashi M, Yokoyama T et al. Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy. J. Nucl. Cardiol. 2002; 6: 632-7. https://doi.org/10.1067/mnc.2002.125915
Raghava K, Bhagwant R, AnishB,Rohit M and SurjitS, Exercise myocardial perfusion imaging to evaluate inducible ischaemia in children with Kawasaki disease. Nuclear Medicine Communications 2011, 32:137-141" https://doi.org/10.1097/MNM.0b013e3283411c67